Articles
+ 2 Articles
Show Remaining Articles
Europe AI & Data Rules Hub
-
AI, Robotics & Biotech Regulation in Europe
-
- Regulating AI-Enabled Products: From Robots to Software
- AI-Enabled Products: The Compliance Stack Explained
- Intended Use: The Switch That Changes Legal Obligations
- On-Device AI and Edge Systems: Compliance and Auditability
- Human Factors in AI Products: Safety and Foreseeable Misuse
- Post-Market Monitoring for AI Products
-
- Machinery Regulation and Intelligent Systems
- Machinery Regulation 2023/1230: What Changes for Smart Machines
- Functional Safety for Intelligent Systems: Practitioner Basics
- Safety Standards for Robots and Machines: How to Use Them
- Foreseeable Misuse: The Safety Concept Teams Underestimate
- Building a Defensible Safety File
-
- AI in Healthcare and Biotech: Regulatory Landscape
- When AI Is a Medical Device: MDR Concepts Explained
- IVDR for AI Diagnostics: Evidence, Performance, and Risk
- Clinical Evaluation for AI: What Evidence Means in Practice
- EMA and AI in Drug Development: What Is Regulated
- Real-World Data and GDPR in Health AI
- From Lab to Market: EMA Pathways for Biotech Products
- Clinical Trials Regulation (CTR) 536/2014: What Changed and Why It Matters
- Good Clinical Practice in Europe: What Regulators Expect
- GMP for Biotech Manufacturing: What EU Inspectors Check
- Biotech Supply Chains: GDP, Cold Chain, and Traceability
- Pharmacovigilance for Biologics: A Practical Operating Model
- Advanced Therapy Medicinal Products (ATMPs): Gene and Cell Therapy Regulation
- Companion Diagnostics Under IVDR: The Biotech–Diagnostics Bridge
- MDR vs IVDR for Digital Biomarkers and Diagnostic Software
- Real-World Evidence (RWE) in EU Biotech: What Counts as Credible
- Orphan Drugs in the EU: Incentives, Evidence Trade-offs, and Compliance
- Paediatric Investigation Plans (PIPs): The Timeline Driver Many Teams Miss
- Labelling and Patient Information in the EU: Biotech-Specific Realities
- Quality by Design (QbD) Without Buzzwords: EU Expectations for Biotech
- Biosimilars in Europe: Comparative Evidence and Regulatory Strategy
- Clinical Trial Transparency in the EU: What Must Be Published and When
- Clinical Evaluation vs Performance Evaluation: MDR/IVDR Evidence Planning
- Show Remaining Articles (8) Collapse Articles
-
- Liability Models for AI-Driven Systems
- Liability in AI Systems: A Practical Map
- Shared Responsibility: When Multiple Parties Contribute to Harm
- Autonomous Systems vs Decision Support: Liability Differences
- Insurance for AI and Robotics Deployments
- Design Choices That Reduce Liability Exposure
- Liability When Biotech Software Fails: Diagnostics, Decision Support, and Harm
- Product Liability and Biotech: When Manufacturing Deviations Become Legal Claims
-
- Compliance Artifacts: What You Need to Produce
- Risk Assessment Workshop: A Step-by-Step Template
- Conformity Assessment in Plain Language
- CE Marking Roadmap for AI-Enabled Products
- Operational Compliance: Monitoring, Updates, and Change Control
- CTIS in Practice: Submission, Amendments, and End-of-Trial Reporting
- Lifecycle Management: Variations, Manufacturing Changes, and Compliance Continuity
- Stability, Shelf Life, and Cold Chain Claims: Evidence Requirements
- Data Integrity in Biotech: ALCOA+ and the Reality of Digital Systems
- Post-Market Surveillance for Biotech-Adjacent Devices and Tests
- EMA Inspections and Readiness: A Practical Preparation Guide
- European Regulation of AI, Robotics, and Biotech Systems
- EU Regulatory Map: AI Act, GDPR, Safety, Liability, Health
- Risk-Based Regulation: Why Europe Regulates by Use Case
- Standards as Compliance Infrastructure: ISO, IEC, CEN/CENELEC
- From Policy to Practice: Building a Compliance Program for Emerging Tech
- Common Misconceptions About EU Tech Regulation
- Biotech in the EU: The Regulatory Map in One Article
- Human Tissues and Cells: EU Rules Biotech Teams Often Overlook
- IP and Regulatory Data Protection: What ‘Data Exclusivity’ Really Means
- A Minimal Compliance Program for Early-Stage EU Biotech Startups